ABSTRACT
INTRODUCTION
The leading cause of mortality and morbidity in diabetic patients is represented by coronary artery disease, and the majority of the deaths in these patients are caused by an acute myocardial infarction (AMI). 1 Among the multiple factors that may influence the prognosis following an AMI, a major contributor is the degree of the left ventricular (LV) remodeling process, which in turn is directly correlated with the scale of the inflammatory reaction in the post-infarction phase. 2 Low-grade inflammation is recognized as playing a significant role in the pathogenesis of type 2 diabetes mellitus (DM) and its complications, but the potential role of this inflammation in intensifying the remodeling process following an AMI is still uncertain. Studies have indicated that elevated circulating levels of highly-sensitive C-reactive protein (hs-CRP), a protein expressing an increased inflammatory status. 3 are associated with the amplitude of the LV remodeling. 4 However, the prognostic value of hs-CRP in the subset of AMI patients, presenting different comorbidities which express a persistent inflammation, is still under debate. [5] [6] [7] Epicardial adipose tissue is a metabolically active visceral adipose tissue, which has been shown to be involved in the pathogenesis of coronary artery diseases progression through secretion of pro-inflammatory cytokines. 8, 9 It has been suggested that a significant increase in mean epicardial fat thickness is present in patients with metabolic syndrome. 10 Moreover, it has been proposed that the inflammatory cytokines released by the epicardial fat surrounding coronary arteries may have a significant contribution to atherosclerosis progression via modulation of coronary artery function. 9 The aim of this study was to assess the correlation between several markers expressing an increased inflammatory status in a diabetic population, such as (1) persistence of elevated circulating levels of hs-CRP, as determined at 7 ± 2 days after an AMI and (2) the epicardial fat thickness, as determined by 2D echocardiography, and the evolution of the condition following an acute myocardial infarction, expressed by: (1) the evolution of ejection fraction and (2) the amplitude of the LV remodeling at 6 months postinfarction.
The Null hypothesis that was tested in this study was that there are no differences between the groups with respect to:
1. Persistence of elevated circulating levels of hs-CRP, as determined at 7 ± 2 days after an AMI;
2. The epicardial fat thickness, as determined by 2D echocardiography;
3. The evolution of the condition following an acute myocardial infarction, expressed by the evolution of ejection fraction and the amplitude of the LV remodeling at 6 months post-infarction.
At the same time, the aim was to assess the prognostic value of a new imagistic marker, the epicardial fat thickness, in predicting the evolution after an AMI in diabetic population.
METHODS
The study included 98 patients (45 with DM and 43 nondiabetic) presenting with an acute myocardial infarction 4
[± 2] days prior to the inclusion in the study.
All the patients received primary PCI with post-procedural TIMI 3 flow, followed by medication including statins, dual antiplatelet therapy, ACE inhibitors and cardioselective beta-blockers in optimal adjusted doses.
Study groupS
In all patients, hs-CRP levels were determined within 4
[± 2] days following the infarction and the patients were divided into the following two groups according to the risk categories 11 and to their hs-CRP levels in the post-acute phase: 
StatiStical analySiS
Statistical analyses were performed using InStat Graph Pad software. Fisher's exact test, and the Student's t-test for age, were used to compare the baseline characteristics of patients. The continuous values are expressed as the mean and standard deviation, and statistical significance was determined using the Mann-Whitney test.
Linear regression was used to assess the correlation between the EF and the RI and the hs-CRP values. Logistic regression analysis was used to identify independent predictors of LV remodeling. The level of significance was set at α = 0.05.
RESULTS
In Group 1, the hs-CRP values were 1.71 ± 0.78 mg/l, and in Table 1) .
The echocardiographic and angiographic assessments at baseline showed no statistically significant differences between the hs-CRP groups in both diabetic and non-diabetic populations in regard to the ejection fraction, the LVED volume (Table 2 ) and the location of the infarction (40.9% vs. 16%, p = 0.13 for anterior infarctions, 40.9% vs.
26%, p = 0.5 for postero-inferior infarctions and 18.18%
vs. 4.34%, p = 0.18 for lateral infarctions).
Six-month evolution of the ef, ventricular remodeling and hs-crp at baSeline
In the diabetic population, the hs-CRP circulating levels at baseline correlated directly with the decrease in the EF from baseline to six months (r = 0.36, p = 0.01) ( Figure 1A ). (Table 3) .
DISCUSSION
This study demonstrated that patients with type 2 DM and AMI, who express an increased inflammatory response at In a seven-year follow-up study on 1045 patients with type 2 diabetes, an elevated hs-CRP level was shown to be an independent risk factor for cardiovascular death. This study indicates that the ventricular remodeling could be influenced by the increase in epicardial fat vol- 
15,16
The Null hypothesis of this study was therefore rejected, as the study indicated significant differences between the groups with respect to persistence of elevated circulating levels of hs-CRP, as determined at 7 ± 2 days after an AMI, the epicardial fat thickness, as determined by 2D echocardiography and the evolution of the condition following an acute myocardial infarction, expressed by the evolution of ejection fraction and the amplitude of the LV remodeling at 6 months post-infarction.
Interestingly, the correlation between the increased inflammatory status and the evolution after an acute myocardial infarction was observed only in the diabetic 
CONCLUSIONS
The present study indicates that in patients with type 2 DM and AMI, the epicardial adipose tissue thickness is 
